Sabra Health Care REIT (SBRA) Stock Analysis & Forecast

Nov 13 close

$20.44−0.12 (−0.6%)

Gekko Brief

AI summaryNov 9 close

Sabra Health Care REIT moves this week on third-quarter results and related developments. The company reported higher normalized funds from operations with continued growth in its senior housing operating portfolio, and management raised full-year normalized FFO guidance midpoint by $0.005 per share, with third-quarter same-store senior housing occupancy reaching 89.2%. Results also included a $100 million write-off tied to a $300 million Recovery Centers of America mortgage loan that was satisfied with a reduced $200 million cash payment. Separately, Huntington Sec initiated coverage with a "strong-buy" rating, and the company declared a quarterly dividend of $0.30 per share, representing a 6.0% annual yield, payable 30 November to holders of record 13 November.

The stock closes at $21.47, up 2.1%, sitting between its 50-day average of $19.88 and 200-day average of $20.02. The GekkoIndex reads 43.4, placing the stock in the Distribution zone, down 12.2 points over the last five readings. Shares trade 33.6% below Gekko Fair Value of $32.34.

The next earnings date falls on 11 February 2027, 93 days out, beyond a typical 20-day holding window. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged -2.4% over 5 years, rising in 2 of them, a pattern worth noting alongside the current Distribution reading.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Sabra Health Care REIT price vs fair value

▲$30.54$20.44Nov ’25May ’26Nov ’26
Close $20.44200-day averageGekko Fair Value $30.54

Sabra Health Care REIT quick facts

Market cap
$5.35B
P/E ratio
76.2
Forward P/E
32.2
EPS, TTM
$0.27
Revenue, TTM
$924.3M
Profit margin
7.7%
Dividend yield
5.72%
Beta
0.64
Volume
2.15M avg 2.71M
1-year return
+8.3%
Typical daily move
±2.6%
Typical 20-day move
±4.3%
50-day average
$19.88
200-day average
$20.06
Next earnings
Feb 11
Shares outstanding
262.0M
52-week range
$17.54$22.77

Sabra Health Care REIT swing-trade checklist

Sabra Health Care REIT scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive2 mixed1 headwind

  • Trendmixed

    Averages disagree

    Close $20.44 sits between the 50-day ($19.88) and 200-day ($20.06) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    54.4, Neutral

    Reading 54.4 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    33.1% below

    Price is 33.1% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 88 days

    Next report Feb 11, 2027, 88 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityheadwind

    −2.7% on average

    From this point in the calendar, the next 20 trading days averaged −2.7% over 5 years, rising in 2 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Sabra Health Care REIT stock chart and price history

Sabra Health Care REIT closed at $20.44 on Nov 13, 2026, +8.3% over the past year, inside a 52-week range of $17.54 to $22.77.

Close50-day average200-day averageVolume
Sabra Health Care REIT share price, past year, with 50-day and 200-day moving averages and volume$18$19$20$21$22DecJan 2026FebMarAprMayJunJulAugSepOctNov20.44

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+6.0%
3 months
+0.6%
6 months
−1.1%
1 year
+8.3%
The full SBRA chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SBRA in Gekko

Follow Sabra Health Care REIT through every session

Put SBRA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track SBRA in GekkoFree for 7 days. No credit card required.

About Sabra Health Care REIT

Sabra Health Care REIT is engaged in the acquisition, financing, and ownership of real estate property. Its core activity involves building up holdings of property assets through purchase and funding arrangements, positioning the company within the real estate investment space. This work of acquiring and holding property is the primary way the company is known.

The company generates its earnings by owning and financing the real estate it acquires, with its business structured around the management of these property holdings. Its operations center on the cycle of obtaining properties, arranging the financing needed to support that ownership, and retaining these assets over time.

Sabra Health Care REIT was founded on May 10, 2010, and its headquarters are located in Tustin, California. The company's shares trade under the ticker SBRA.

Sector
Finance
Website
sabrahealth.com

Sabra Health Care REIT GekkoIndex: the smart money zone

Sabra Health Care REIT’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.4, in the Neutral zone, up 9.5 points over five sessions.

010054.4Neutral

Up 9.5 points over five sessions, from the Distribution zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying25+0.9%+0.9%+5.0%+5.5%
Accumulation161+0.6%+1.6%+2.7%+4.7%
Neutral (current zone)434+0.2%+0.3%+0.7%+2.5%
Distribution35−0.5%−0.6%−1.4%+2.4%
Selling0Not available

Average SBRA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the SBRA price, zone by zone.Track SBRA in Gekko

Is Sabra Health Care REIT stock overvalued? Gekko Fair Value

Sabra Health Care REIT trades 33.1% below Gekko Fair Value of $30.54, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Sabra Health Care REIT shares are worth, recalculated every trading day.

$30.54

Gekko Fair Value, Nov 14, 2026

33.1% Undervalued

At the end of Aug 2026 the price was 44.3% below the estimate.

Gekko Fair ValueShare price, month end
$31$20Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open SBRA in Gekko

Sabra Health Care REIT insider and Congress trading

No open-market insider purchases were filed for Sabra Health Care REIT, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for SBRA in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every SBRA insider filing, plotted on the chart in Gekko.Open SBRA in Gekko

Congress trades last 90 days

No trades in SBRA were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for SBRA, plotted on the chart in Gekko.Open SBRA in Gekko

Buybacks

Sabra Health Care REIT has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$8.25M
As a share of market cap
0.15%

From company filings.

Sabra Health Care REIT earnings: next date and track record

Sabra Health Care REIT reports on Feb 11, 2027 (88 days away), and beat the EPS estimate in 3 of its last 8 reports.

3 of 8reports beat the EPS estimate
±2.4%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−1.7%May ’24−0.1%Aug ’24−4.8%Oct ’24+3.2%Feb ’25+4.6%May ’25−0.6%Aug ’25−1.6%Oct ’25+2.9%Feb ’26

Last earnings call, Feb 12, 2026 AI summary

What they said
Sabra reported a strong fourth quarter 2025 driven by its SHOP (senior housing operating) portfolio. Management highlighted sequential and year-over-year revenue, occupancy, and RevPAR gains, with particular strength in Canada. The company invested heavily in SHOP assets (~$150 million in the quarter; ~$450 million year-to-date) and has ~$240 million of awarded transactions (predominantly SHOP) with most expected to close in Q1/early Q2 2026. Same-store managed senior housing revenue grew 6.4% YoY and occupancy improved materially (up 160 bps YoY to 87.9% overall; Canadian same-store occupancy 94.2%). Management reported normalized FFO/AFFO metrics for the quarter and introduced full-year 2026 guidance (including net income and FFO ranges). The transition facilities (Holiday portfolio) lag but are expected to recover and add to SHOP NOI growth. Management discussed capital allocation, ongoing deal flow, modest cap-rate compression but continued ability to find assets in the mid-to-high single-digit cap-rate range, and their operational experience and infrastructure as a differentiator. Regulatory trends in Medicaid/Medicare were discussed as normalizing after pandemic-driven peaks. Overall tone from management was confident and constructive, with some acknowledged uncertainties (loan maturity later in 2026, Holiday transitions, and industry competition).
Guidance
Company provided full-year 2026 guidance: net income $0.60 to $0.64 per diluted share; FFO and normalized FFO approx. $1.49 to $1.50 per share; management earlier referenced guidance implying ~4.9% to 5.4% growth at the midpoint for normalized FFO and normalized AFFO. (Guidance for some metrics was partially truncated in the transcript; the company emphasized normalized FFO/AFFO growth in the ~mid-single-digit range.)
Risks flagged
Risks mentioned or implied: uncertainty around the RCA loan maturing at year-end (though tenant is servicing debt); Holiday transition assets lagging and timeline for their recovery is uncertain; competitive pressure and cap-rate compression as more investors/REITs/private equity enter SHOP; expected normalization (reduction) of Medicaid and Medicare rate increases toward historical averages, which may be a headwind versus recent outsized increases; general macro/interest-rate environment and execution risk as portfolio scales.
ReportedEPSSurpriseRevenueSurpriseMove
Feb 12, 2026$0.38
est $0.17
+123.5%$211.9M
est $198.0M
+7.0%+2.9%
Oct 29, 2025$0.17
est $0.18
−8.6%$190.0M
est $202.0M
−5.9%−1.6%
Aug 4, 2025$0.38
est $0.37
+2.7%$189.2M
est $187.5M
+0.9%−0.6%
May 6, 2025$0.17
est $0.14
+19.3%$183.5M
est $182.5M
+0.6%+4.6%
Feb 25, 2025$0.17
est $0.17
−0.5%——+3.2%
Oct 31, 2024$0.13
est $0.16
−18.7%$178.0M
est $175.6M
+1.3%−4.8%
Aug 7, 2024$0.10
est $0.15
−33.3%$178.5M
est $166.0M
+7.5%−0.1%
May 8, 2024$0.11
est $0.14
−21.4%$172.2M
est $162.0M
+6.3%−1.7%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Sabra Health Care REIT stock forecast and analyst price targets

Analysts’ average 12-month price target for Sabra Health Care REIT is $22.64, +10.8% from the last close, from 6 firms rating the stock in the last 90 days.

$22.64consensus 12-month target, +10.8% from the last close
Low $20High $25
Buy2
Hold4
Sell0

Each firm’s latest rating in the last 90 days: 6 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11UBSHold, reiterated$22+7.6%
Nov 9Bank of America SecuritiesBuy, reiterated$25+22.3%
Nov 3Wells FargoBuy, maintained$21+2.7%
Nov 3ScotiabankHold, maintained$20−2.2%
Oct 19Wells FargoBuy, reiterated$21+2.7%
+0.7%average 20-day move after past Neutral readings
−2.7%average move over the next 20 trading days in the last 5 years
±2.6%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Sabra Health Care REIT seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Sabra Health Care REIT averaged −2.7% across the last 5 years, rising in 2 of them.

Next 20 trading days, by year

−9.2%2021+0.9%2022−1.1%2023−4.1%2024+2.9%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−1.3%1 of 5
Next 10 trading days−1.1%3 of 5
Next 15 trading days−1.3%2 of 5
Next 20 trading days−2.7%2 of 5
Next 30 trading days−3.3%2 of 5

For scale, SBRA’s typical 20-trading-day move in either direction is about 4.3%.

Sabra Health Care REIT market cap and key statistics

Sabra Health Care REIT’s market cap is $5.35B, with a P/E ratio of 76.2 and revenue of $924.3M over the last twelve months.

Valuation

Market cap
$5.35B
P/E ratio
76.2
Forward P/E
32.2
EPS, TTM
$0.27
Gekko Fair Value
$30.54

Trading

Volume
2.15M
Avg volume, 20 days
2.71M
52-week high
$22.77
52-week low
$17.54
Shares outstanding
262.0M

Financials

Revenue, TTM
$924.3M
Profit margin
7.7%
Return on equity
2.5%
Quarterly earnings growth, YoY
+22.2%

Risk and income

Beta
0.64
Typical daily move
±2.6%
Typical 20-day move
±4.3%
Dividend yield
5.72%

Sabra Health Care REIT stock news this week

3 headlines about Sabra Health Care REIT from the past week, newest first, each linking to the publisher.

More stocks

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Finance

Sabra Health Care REIT stock FAQ

What is Sabra Health Care REIT’s market cap?

Sabra Health Care REIT’s market cap is $5.35B at the Nov 13, 2026 close of $20.44, with 262.0M shares outstanding. The shares trade on a P/E ratio of 76.2.

What is the Sabra Health Care REIT stock forecast?

The consensus analyst 12-month price target for Sabra Health Care REIT is $22.64, +10.8% from the last close. Of the 6 firms that rated the stock in the last 90 days, 2 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Sabra Health Care REIT stock overvalued or undervalued?

On Gekko’s estimate Sabra Health Care REIT is undervalued: the Nov 13, 2026 close of $20.44 is 33.1% below Gekko Fair Value of $30.54. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Sabra Health Care REIT report earnings next?

Sabra Health Care REIT is expected to report on Feb 11, 2027 (88 days away). Analysts expect earnings of $0.16 per share on revenue of $246.9M. Sabra Health Care REIT beat the earnings estimate in 3 of its last 8 reports, moving 2.4% on average across the report.

What is Sabra Health Care REIT’s 52-week high and low?

Sabra Health Care REIT’s 52-week high is $22.77 and its 52-week low is $17.54; it closed at $20.44 on Nov 13, 2026, +8.3% over the past year.

Is Sabra Health Care REIT stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Sabra Health Care REIT the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.